0.6277

4.08% 0.0246

Vistagen Therapeutics Inc (VTGN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$0.6031

Aprire:

$0.5881

Volume 24 ore:

1.19M

Relative Volume:

1.51

Capitalizzazione di mercato:

$24.87M

Reddito:

$1.04M

Utile/perdita netta:

$-67.50M

Rapporto P/E:

-0.3266

EPS:

-1.9222

Flusso di cassa netto:

$-60.67M

1 W Prestazione:

+12.01%

1M Prestazione:

-2.89%

6M Prestazione:

-84.50%

1 anno Prestazione:

-70.25%

Intervallo 1D:

$0.5851

$0.65

Intervallo di 1 settimana:

$0.5502

$0.65

Portata 52W:

$0.43

$5.14

Vistagen Therapeutics Inc Stock (VTGN) Company Profile

Nome

Vistagen Therapeutics Inc

Settore

Healthcare (1116)

Industria

Biotechnology (622)

Telefono

650-577-3600

Indirizzo

343 ALLERTON AVENUE, SOUTH SAN FRANCISCO

Dipendente

Cinguettio

@vistagen

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

VTGN's Discussions on Twitter

Compare VTGN vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
VTGN Vistagen Therapeutics Inc	0.6277	24.87M	1.04M	-67.50M	-60.67M	-1.9222
VRTX Vertex Pharmaceuticals Inc	441.20	112.22B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	750.57	79.35B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	849.04	52.80B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	309.66	41.32B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	323.87	35.95B	5.36B	287.73M	924.18M	2.5229

Vistagen Therapeutics Inc Stock (VTGN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-17	Downgrade	Jefferies	Buy → Hold
2025-12-17	Downgrade	Maxim Group	Buy → Hold
2025-12-17	Downgrade	Stifel	Buy → Hold
2025-12-17	Downgrade	William Blair	Outperform → Mkt Perform
2023-12-07	Aggiornamento	Jefferies	Hold → Buy
2023-08-07	Aggiornamento	Maxim Group	Hold → Buy
2022-07-22	Downgrade	Jefferies	Buy → Hold
2022-07-22	Downgrade	Robert W. Baird	Outperform → Neutral
2022-07-22	Downgrade	William Blair	Outperform → Mkt Perform
2021-05-20	Iniziato	Robert W. Baird	Outperform
2021-02-18	Iniziato	Jefferies	Buy
2021-01-04	Aggiornamento	William Blair	Mkt Perform → Outperform
2018-06-27	Iniziato	Maxim Group	Buy
2018-02-08	Reiterato	Chardan Capital Markets	Buy
2017-03-28	Iniziato	Maxim Group	Buy

Mostra tutto

Vistagen Therapeutics Inc Borsa (VTGN) Ultime notizie

Apr 17, 2026

Vistagen Reports Fiscal Year 2026 First Quarter Financial Results and Corporate Update - ADVFN

Apr 17, 2026

Apr 16, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Vistagen Therapeutics, Inc. (VTGN) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

Apr 16, 2026

2026-04-16 | Bronstein, Gewirtz & Grossman, LLC Encourages Vistagen Therapeutics, Inc. (VTGN) Shareholders to Inquire about Securities Investigation | NDAQ:VTGN | Press Release - Stockhouse

Apr 16, 2026

Apr 15, 2026

Vistagen Therapeutics Inc (MEX:VTGN) Stock Price & 30 Year Financial Data - GuruFocus

Apr 15, 2026

Apr 14, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Vistagen Therapeutics, Inc. (VTGN) And Encourages Shareholders to Connect - ACCESS Newswire

Apr 14, 2026

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Apr 14, 2026

Vistagen Therapeutics, Inc. Files Form 8-K with SEC – Company Information, Address, and Stock Details (April 2026) - Minichart

Apr 14, 2026

Apr 13, 2026

Vistagen Therapeutics grants stock options to executives and employees - Investing.com

Apr 13, 2026

Vistagen Therapeutics grants stock options to executives and employees By Investing.com - Investing.com UK

Apr 13, 2026

VistaGen Therapeutics Grants Broad Employee Retention Stock Options - TipRanks

Apr 13, 2026

Vistagen awards stock options to CEO Shawn K. Singh and CFO Nick B. Tressler - TradingView — Track All Markets

Apr 13, 2026

[8-K] Vistagen Therapeutics, Inc. Reports Material Event - Stock Titan

Apr 13, 2026

Institution Moves: Will Vistagen Therapeutics Inc outperform during market ralliesPortfolio Growth Summary & AI Forecasted Entry and Exit Points - baoquankhu1.vn

Apr 13, 2026

Apr 12, 2026

2026-04-12 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Vistagen Therapeutics, Inc. (VTGN) And Encourages Shareholders to Reach Out | NDAQ:VTGN | Press Release - Stockhouse

Apr 12, 2026

Trading Recap: What is the next catalyst for Vistagen Therapeutics IncInsider Selling & Low Volatility Stock Suggestions - baoquankhu1.vn

Apr 12, 2026

Apr 11, 2026

Vistagen Therapeutics Inc (MEX:VTGN) Stock HoldersInstitutional & Insider Ownership - GuruFocus

Apr 11, 2026

Is Vistagen Therapeutics Inc a potential multi bagger2026 Reactions & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn

Apr 11, 2026

Hedge Fund Bets: Can Vistagen Therapeutics Inc sustain earnings growthMarket Volume Summary & Daily Profit Maximizing Trade Tips - baoquankhu1.vn

Apr 11, 2026

Apr 10, 2026

Quarterly Risk: Can Vistagen Therapeutics Inc sustain earnings growth2026 Growth vs Value & Weekly Momentum Picks - baoquankhu1.vn

Apr 10, 2026

Vistagen Therapeutics Inc (MEX:VTGN) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus

Apr 10, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Vistagen Therapeutics, Inc. (VTGN) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Apr 10, 2026

Apr 09, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Vistagen Therapeutics, Inc. (VTGN) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Apr 08, 2026

Bull Run: Should value investors consider Vistagen Therapeutics Inc2026 Breakouts & Daily Profit Focused Stock Screening - baoquankhu1.vn

Apr 08, 2026

Apr 07, 2026

RSI Check: Why is Vistagen Therapeutics Inc stock going downBull Run & Real-Time Volume Analysis Alerts - baoquankhu1.vn

Apr 07, 2026

Apr 06, 2026